Men's Health, Hormonal Optimisation & Performance: The Complete UK Guide

Men in the UK are statistically less likely than women to attend routine health appointments, seek help for persistent symptoms, or engage proactively with their own healthcare. The consequences of this pattern are measurable: men have a lower average life expectancy, higher rates of cardiovascular disease, and are more likely to receive a late-stage diagnosis of conditions that were developing silently for years.

Private blood testing addresses this gap directly. Rather than waiting for symptoms to reach a threshold that prompts a GP visit, a comprehensive men's health panel establishes a detailed biological baseline — identifying early-stage risk across hormonal, cardiovascular, metabolic, and nutritional systems when intervention is most effective and lifestyle changes can still produce meaningful results.

The goal is not simply the absence of disease. It is understanding your own physiology precisely enough to protect it, optimise it, and sustain your performance across every decade of life.

The endocrine system is the body's hormonal signalling network — a collection of glands that produce chemical messengers regulating metabolism, energy, muscle growth, mood, reproduction, and stress response. In men, the key endocrine organs include the testes, adrenal glands, thyroid, pituitary, and pancreas.

These systems do not operate independently. Hormonal imbalance in one area — elevated cortisol from chronic stress, for example, or declining thyroid function — exerts downstream effects across multiple others. This is why a meaningful men's hormonal assessment measures a broad panel rather than a single marker.

Testosterone is the primary androgen in men — a steroid hormone that governs a remarkable breadth of physiological function. Its influence extends well beyond the reproductive system into cardiovascular health, metabolic regulation, bone density, cognitive performance, and psychological wellbeing.

What does testosterone actually do?

• Muscle mass and physical strength

  Testosterone stimulates protein synthesis and inhibits muscle breakdown, making it the primary driver of lean body mass in men.

• Bone density

  Testosterone maintains bone mineral density throughout adulthood; declining levels are a significant contributor to male osteoporosis.

• Mood and cognitive function

  Adequate testosterone is associated with positive mood, motivation, and working memory; low levels are associated with depression, poor concentration, and reduced drive.

• Cardiovascular health

  Testosterone exerts a protective effect on the cardiovascular system; low levels are independently associated with increased cardiometabolic risk (Hackett et al., 2023).

• Libido and sexual function

  Testosterone is the primary determinant of male sexual desire and contributes to erectile function alongside vascular and neurological factors.

Total vs. free testosterone: why both matter

Most testosterone in the blood is bound to carrier proteins — primarily SHBG (Sex Hormone-Binding Globulin) and, to a lesser extent, albumin. Only the free fraction — approximately 1–3% of total testosterone — is biologically active and available to tissues.

A man can have a total testosterone reading within the laboratory reference range while experiencing genuinely low testosterone symptoms, because his SHBG is elevated — leaving insufficient free testosterone for physiological needs. This is why measuring total testosterone in isolation is insufficient; a comprehensive assessment must include free testosterone (calculated or directly measured) and SHBG to accurately determine androgenic status (Hackett et al., 2023).

How testosterone is measured

Testosterone testing requires a fasting, morning blood sample — ideally collected between 7:00 and 11:00 am, as testosterone follows a diurnal pattern and peaks in the early morning. A single reading may not be definitive; the British Society for Sexual Medicine recommends confirmatory testing before clinical decisions are made (Hackett et al., 2023).

Testosterone production in men declines gradually from approximately the age of 30 onwards, at an average rate of around 1–2% per year (National Health Service [NHS], 2022). For many men, this decline is gradual enough to be imperceptible. For others — particularly those with additional risk factors such as obesity, type 2 diabetes, chronic stress, or poor sleep — the drop is more pronounced and produces a recognisable cluster of symptoms.

Late-onset hypogonadism (LOH) — sometimes colloquially referred to as the “male menopause” — is the clinical term for symptomatic testosterone deficiency in ageing men. Unlike female menopause, which involves a relatively rapid hormonal transition, LOH develops slowly and its symptoms are frequently attributed to other causes.

Symptoms of low testosterone

• Persistent fatigue and reduced energy, regardless of sleep quality
• Loss of muscle mass and increased body fat, particularly around the abdomen
• Reduced libido and changes in sexual function
• Low mood, irritability, and reduced motivation
• Poor concentration and memory difficulties
• Decreased bone density and increased fracture risk
• Reduced physical stamina and slower recovery from exercise

The British Society for Sexual Medicine guidelines highlight that low testosterone is associated with significantly elevated risk of type 2 diabetes, metabolic syndrome, and cardiovascular disease — making it a genuine long-term health concern rather than simply a quality-of-life issue (Hackett et al., 2023).

Oestradiol in men

Testosterone is partially converted into oestradiol (a form of oestrogen) through a process called aromatisation, which occurs primarily in adipose (fat) tissue. Some oestradiol is essential in men — it plays important roles in bone health, cardiovascular function, and libido. However, excess oestradiol — particularly in men who are overweight, as adipose tissue contains high concentrations of the aromatase enzyme — is associated with reduced libido, erectile difficulties, mood disturbance, and gynaecomastia (breast tissue development). Measuring oestradiol alongside testosterone provides the full hormonal picture.

Prolactin

Prolactin, produced by the pituitary gland, is primarily associated with lactation in women — but it is also present in men and plays a role in regulating testosterone. Elevated prolactin (hyperprolactinaemia) can suppress the pituitary signals that stimulate testosterone production, leading to low testosterone, reduced libido, and fertility difficulties. It can result from a benign pituitary tumour (prolactinoma), medication side effects, or chronic stress. Prolactin is a standard inclusion in a comprehensive male hormone panel.

Thyroid function

Thyroid disorders are less prevalent in men than in women but remain a significant and frequently missed cause of fatigue, weight changes, and mood disturbance in men. An underactive thyroid (hypothyroidism) can mimic the symptoms of low testosterone almost exactly — making it essential to assess thyroid function as part of any hormonal investigation. A full thyroid panel includes TSH, free T3, free T4, and — where autoimmune thyroid disease is suspected — thyroid peroxidase (TPO) antibodies.

Cardiovascular disease is the leading cause of death in men in the UK, accounting for approximately one in four male deaths. Men develop coronary heart disease on average a decade earlier than women — and the underlying process, atherosclerosis (the build-up of fatty plaques in arterial walls), begins silently, often long before symptoms appear.

Beyond the basic lipid panel

Standard cardiovascular blood tests typically measure total cholesterol, LDL-C (so-called “bad” cholesterol), HDL-C (“good” cholesterol), and triglycerides. While these provide a useful starting point, they are insufficient for accurately stratifying individual cardiovascular risk.

Apolipoprotein B (ApoB) is the protein found on every atherogenic lipoprotein particle in the blood. Each particle capable of contributing to arterial plaque carries exactly one ApoB molecule — meaning ApoB directly enumerates the dangerous particle count, rather than estimating the cholesterol mass they carry. A systematic analysis of over 500,000 individuals published in JAMA Cardiology found ApoB to be significantly more accurate than either LDL-C or non-HDL-C in predicting cardiovascular risk (Sehayek et al., 2025). Despite this, it remains routinely absent from NHS standard panels.

Additional advanced cardiovascular markers of particular relevance to men:

• Lipoprotein(a) [Lp(a)] — a genetically determined, largely unmodifiable risk factor that affects approximately one in five people and is not addressed by standard statin therapy; one-time testing is recommended for all adults
• High-sensitivity CRP (hs-CRP) — a sensitive marker of arterial inflammation; levels above 3.0 mg/L indicate substantially elevated cardiovascular risk
• Homocysteine — an amino acid associated with endothelial damage and thrombotic risk when elevated; responsive to B vitamin optimisation
• HbA1c and fasting insulin — metabolic dysfunction and cardiovascular disease are deeply intertwined; these markers assess both simultaneously

Men are at particularly elevated risk of type 2 diabetes and metabolic syndrome — driven by the tendency for male physiology to preferentially deposit fat viscerally (around the abdominal organs) rather than subcutaneously. Visceral adiposity is directly associated with insulin resistance, systemic inflammation, and elevated cardiovascular risk.

HbA1c: your three-month blood sugar average

The HbA1c test measures the proportion of red blood cells that have become glycated — coated with glucose — over the preceding 8–12 weeks. Because red blood cells have a lifespan of approximately three months, HbA1c provides a reliable average of blood sugar control across that entire period, making it far more meaningful than a single fasting glucose reading.

Per National Institute for Health and Care Excellence (NICE, 2022) guidance:

From a longevity and performance standpoint, optimal HbA1c sits below 35 mmol/mol. Readings in the upper normal range carry graduated long-term risk to vascular, neurological, and renal health — and to testosterone levels, as metabolic dysfunction and androgen deficiency are bidirectionally linked.

Fasting insulin and insulin resistance

Critically, HbA1c and fasting glucose can appear normal for years while insulin resistance is already established and worsening. Fasting insulin — and the calculated HOMA-IR index derived from it — can detect impaired insulin sensitivity a decade or more before standard glucose markers become abnormal. For men with central weight gain, fatigue, or a family history of type 2 diabetes, this earlier detection window is clinically valuable.

The prostate is a walnut-sized gland located beneath the bladder in men, surrounding the urethra. It produces fluid that forms part of semen. Prostate conditions — including benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer — become increasingly prevalent with age.

Prostate cancer is the most commonly diagnosed cancer in men in the UK, with more than 52,000 new diagnoses annually. Like many cancers, it is often asymptomatic in its early, most treatable stages.

PSA testing: what it measures and what it means

Prostate-Specific Antigen (PSA) is a protein produced by prostate cells. Small amounts are normally present in the blood, but elevated levels can indicate prostate inflammation, enlargement, or cancer. PSA testing is therefore a useful screening tool — but one that requires careful clinical interpretation.

The UK National Screening Committee (2025) recently issued updated draft recommendations on prostate cancer screening, noting that PSA results require contextualised clinical assessment, as PSA can be elevated by benign causes (including vigorous exercise, infection, and sexual activity in the preceding 48 hours) and because a proportion of prostate cancers produce little or no elevation. The clinical consensus is that PSA testing is most useful as part of a broader clinical conversation — particularly in men over 50, or over 45 in those with a family history or of African heritage, in whom risk is significantly elevated.

PSA testing as part of a private health panel provides men with a baseline reading — and the opportunity to track changes over time — within a context of proper clinical interpretation and, where indicated, timely onward referral.

While blood testing reveals what your hormones are doing, the lifestyle factors driving those levels are equally important to understand. Several modifiable behaviours have a particularly strong and well-evidenced impact on male hormonal health.

Sleep: the single most powerful hormonal lever

The majority of daily testosterone production occurs during sleep — specifically during the slow-wave and REM sleep stages. A seminal study published in JAMA found that healthy young men who slept for fewer than five hours per night for just one week experienced a 10–15% reduction in testosterone levels — equivalent to ageing 10–15 years in androgenic terms (Leproult & Van Cauter, 2011). The effects were rapid, reversible, and dose-dependent.

Sleep also regulates cortisol (which is inversely related to testosterone), growth hormone (which peaks during deep sleep and drives muscle repair), and insulin sensitivity (which deteriorates markedly with chronic sleep restriction). For men seeking to optimise their hormonal profile, consistent sleep of 7–9 hours per night is not a lifestyle luxury — it is a physiological requirement.

Physical activity and resistance training

Resistance training is among the most effective non-pharmacological interventions for supporting testosterone levels, improving insulin sensitivity, reducing visceral adiposity, and maintaining bone density. Both acute testosterone elevation following heavy compound exercise and longer-term hormonal benefits from sustained training programmes are well established in the literature. Conversely, chronic overtraining without adequate recovery can suppress the HPG (hypothalamic-pituitary-gonadal) axis and reduce testosterone — making recovery monitoring as important as training stimulus.

Body composition and adiposity

Adipose tissue — particularly visceral fat — contains high concentrations of the enzyme aromatase, which converts testosterone to oestradiol. Men with higher levels of visceral fat therefore tend to have lower testosterone and higher oestradiol, compounding both hormonal and metabolic risk. Addressing body composition through diet and exercise does not merely improve metabolic markers — it directly supports hormonal balance.

Stress and cortisol

Chronic psychological stress drives sustained elevation of cortisol, which directly suppresses the HPG axis and inhibits testosterone production. It also disrupts sleep, promotes visceral fat accumulation, impairs insulin sensitivity, and elevates inflammatory markers. Blood testing that includes morning cortisol and DHEA-S can quantify adrenal load and provide a basis for targeted intervention.

Nutritional deficiencies are among the most commonly overlooked contributors to suboptimal male health — particularly in men who are training hard, managing high stress, or eating a restricted diet. Several key micronutrients have a direct and well-evidenced bearing on hormonal and physical performance.

Vitamin D

Vitamin D functions as a steroid hormone rather than a conventional vitamin, binding to receptors throughout the body including in testicular cells. Research has demonstrated that vitamin D deficiency is associated with reduced testosterone levels, and that supplementation in deficient men can support androgenic function alongside its well-established benefits for bone density and immune regulation (Harrison & Ghosh, 2023). Public Health England estimates that approximately one in five UK adults has low vitamin D, with deficiency peaking between October and April due to limited ultraviolet B exposure. Blood testing establishes your baseline 25-OH vitamin D level so that supplementation can be targeted precisely rather than guessed.

Zinc and magnesium

Zinc is an essential cofactor in testosterone synthesis and is lost in significant quantities through sweat — making athletes and heavily training men particularly susceptible to depletion. Magnesium is required for over 300 enzymatic processes, including those involved in energy production, muscle function, and sleep regulation. Both are frequently sub-optimal in men eating Western diets, yet both are readily measurable and correctable.

Ferritin (iron stores)

Low ferritin — the protein that stores iron in tissues — is a common and frequently undetected cause of fatigue and reduced exercise capacity in men. Because ferritin can be depleted months before haemoglobin falls, a standard blood count may appear entirely normal while iron stores are critically low. Athletes, men eating a plant-forward diet, and frequent blood donors are at particular risk.

Active B12

Vitamin B12 is essential for red blood cell production, neurological function, and DNA synthesis. Standard total serum B12 can appear normal even when functional B12 is insufficient; active B12 (holotranscobalamin) measures only the fraction available to cells, providing a more clinically accurate assessment. Men taking metformin for type 2 diabetes or prediabetes are at particularly elevated risk of B12 depletion, as the medication impairs intestinal B12 absorption.

1. 1.Hackett, G., Kirby, M., Rees, R. W., Jones, T. H., Muneer, A., Livingston, M., Ossei-Gerning, N., David, J., Foster, J., Kalra, P. A., & Ramachandran, S. (2023). The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice. The world journal of men's health, 41(3), 508–537.
2. 2.Harrison, S., & Ghosh, S. (2023). The effect of vitamin D supplementation on muscle mass, muscle strength and muscle function in the elderly: A systematic review and meta-analysis. Aging Medicine and Healthcare, 14(4), 172-181.
3. 3.Leproult, R., & Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173–2174.
4. 4.National Health Service. (2022). The 'male menopause'.
5. 5.National Institute for Health and Care Excellence. (2022). Type 2 diabetes in adults: Management (NICE Guideline NG28).
6. 6.Sehayek, D., Cole, J., Björnson, E., Wilkins, J. T., Mortensen, M. B., Dufresne, L., Pencina, K. M., Pencina, M. J., Thanassoulis, G., & Sniderman, A. D. (2025). ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. Journal of clinical lipidology, 19(4), 844–859.
7. 7.UK National Screening Committee. (2025). Draft recommendations on prostate cancer screening issued.